levothyroxine sodium NDC 47781-657

Product information

Brand name (proprietary)

levothyroxine sodium

Generic name (nonproprietary)

levothyroxine sodium

Active ingredients

Levothyroxine sodium — 125 ug/1

Dosage form

Tablet

Route

Oral

Labeler

Alvogen, Inc.

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 021116

Marketing start

May 7, 2019

Listing expires

Dec 31, 2027

Other FDA classes

Thyroxine (Chemical structure)

Identifiers

Product ID 47781-657_3b8c38aa-ac99-1c0d-42f3-4fe8881125dcSPL ID 3b8c38aa-ac99-1c0d-42f3-4fe8881125dc

Pharmacologic class

l-Thyroxine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N447781065710 followed by a unit qualifier and the quantity Copy

Package 47781-0657-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under NDA 021116

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 39.